Diabetic neuropathy is one of the most common complications of diabetes. Patients suffering from diabetic neuropathy often report burning pain in foot. The rising prevalence of diabetic neuropathy can be seen worldwide. Around 83% people in the US are suffering from diabetic neuropathy. According to Japanese study around 298 people were diagnosed with diabetic neuropathy in 2017.
According to MRFR analysis, the global diabetic neuropathy treatment market is expected to register a CAGR of 5.1% during the forecast period of 2019 to 2025 and was valued at USD 5.80 Billion by 2025.
Segmentation
The global diabetic neuropathy treatment market has been segmented based on disorder, treatment, and end user.
The market, based on disorder, has been divided into peripheral neuropathy, autonomic neuropathy, proximal neuropathy, and focal neuropathy. The peripheral neuropathy segment is likely to be the largest during the review period due to a growing aging population and increasing prevalence of peripheral neuropathy globally. Around 1.3 million Americans are diagnosed with peripheral neuropathy every year. The autonomic neuropathy segment is predicted to be the fastest-growing due to the rising prevalence of the disorder in the elderly population.
Request Free Sample Copy of Report with Detailed Impact Analysis of Covid-19:https://www.marketresearchfuture.com/sample_request/8359
The global diabetic neuropathy treatment market has been segmented, on the basis of treatment, into drugs, transcutaneous electrical nerve stimulation (TENS), and others. The drugs segment is expected to hold the majority share of the market. The drugs help increase muscle strength and quicken the recovery process. The transcutaneous electrical nerve stimulation segment is expected to be the fastest-growing due to the increasing use of this treatment for diabetic neuropathy. The cost of the treatment is also less as compared to other treatment types.
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of diabetic neuropathy and rising per capita healthcare expenditure.
The diabetic neuropathy treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada.
Have Any Query? Connect with Our Research Expert 24*7:https://www.marketresearchfuture.com/enquiry/8359
The European diabetic neuropathy treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
Key Players
Some of the key players in the global diabetic neuropathy treatment market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Eli Lilly and Company (US), Johnson & Johnson (US), GlaxoSmithKline Plc (UK), Lupin Limited (India), Glenmark Pharmaceuticals Limited (India), Depomed, Inc (US), Astellas Pharma Inc (Japan), Pfizer Inc (US), MEDA Pharma GmBH & Co. KG (Germany).
To Read Full Summary of Report:https://www.marketresearchfuture.com/reports/diabetic-neuropathy-treatment-market-8359
About Market Research Future:
Market Research Future (MRFR) is a world-renowned market research company that offers a wide range of services, complete with accurate and precise analysis about diverse markets, sub-markets and target consumers. Our approach is a combination of extensive information and multiple data sources that help provide an exhaustive comprehension about the latest major developments to the client, in addition to future events and what measures and decisions to take on the basis of the same.
Our fast emerging market research firm is armed with an adept research analysts’ team that focuses on gathering useful data and analytics in terms of economic and technological advances. Our proficient analysts conduct industrial visits in a bid to achieve reliable and accurate information from established market participants. One of our foremost objectives is to keep the client well-versed with all the lucrative opportunities as well as challenges surrounding various global markets. We offer step-by-step guidance to our clients, through consulting and strategic services, enabling them to arrive at a practical and effective decision.